A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disorders

Abstract Background Mass spectrometry-based quantitative proteomics has a demonstrated utility in increasing the diagnostic yield of mitochondrial disorders (MDs) and other rare diseases. However, for this technology to be widely adopted in routine clinical practice, it is crucial to accurately esti...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Francisco Santos Gonzalez, Daniella H. Hock, David R. Thorburn, Dylan Mordaunt, Nicholas A. Williamson, Ching-Seng Ang, David A. Stroud, John Christodoulou, Ilias Goranitis
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2024-11-01
Ráidu:	Orphanet Journal of Rare Diseases
Fáttát:	Proteomics Mitochondrial disorders Micro-costing Functional genomics Health economics
Liŋkkat:	https://doi.org/10.1186/s13023-024-03462-w
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!